Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Since 2016 both digestive neuroendocrine neoplasms (D-NENs) and non-digestive NENs (ND-NENs) cases are treated within NETwerk, an ENETS Center of Excellence
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Vandamme T, De Backer L, Dero I, Galdermans D, Abrams P,
Keywords: non-digestive NENs, gastroenteropancreatic NENs,
Introduction: Neuroendocrine Noplasms (NEN) are rare tumours, but their incidence is clearly increasing in our country due to the improvement of diagnostic means, in particular the generalization of immunohistochemical techniques. The digestive location represents more than 70% of the cases. The anatomopathological study enables to classify the NEN in different prognostic grades according to the degree of differentiation, mitotic index and Ki67.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Belabdi D
Authors: Belabdi D, Mekarnia A, Ouzit S, Ainouche A, Oukkal M,
Keywords: Digestive neuroendocrine neoplasm, immunohistochemical profil, WHO classification 2017,
Introduction: Peritoneal carcinomatosis (PC) is present in 10-30% of digestive neuroendocrine neoplasms (DNENs), affecting prognosis and quality of life with recurrent abdominal pain and bowel obstruction
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: merola e
Authors: Merola E, Prasad V, Pascher A, Denecke T, Arsenic R,
Keywords: peritoneal carcinomatosis, neuroendocrine, bowel obstruction,
Introduction: FOLFOX has been poorly investigated in digestive NEN (DNENs), mostly in small cohorts.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Dal Buono A, Merola E, Delle Fave G, Wiedenmann B, Pavel M,
Keywords: FOLFOX, tolerability, tumor response.,
Introduction: Chromogranin A (CgA) is the most frequently used biomarker in digestive neuroendocrine neoplasms (DNENs) but its real usefulness is still unclear
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Merola E, Delle Fave G, Blankenstein O, Wiedenmann B, Pavel M,
Keywords: CgA, clinical usefulness, ≥ 50% increase,